- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced or Metastatic NSCLC
Total 1886 results
-
Mirati Therapeutics Inc.Approved for marketingMetastatic Cancer | Advanced Cancer | Malignant NeoplasmUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI); Palo Alto Research CenterCompletedLocally Advanced Breast Cancer | Metastatic (Stage IV) Breast Cancer | Stage III-IV Breast Cancer or InflammatoryUnited States
-
SynDevRx, Inc.CompletedAdvanced Solid Tumors | Metastasis | Neoplasm | Advanced MalignancyUnited States
-
howard safranThe Miriam Hospital; Rhode Island HospitalTerminatedNSCLC | Lung Cancer | Metastatic Lung Cancer | Non-small Cell Lung CancerUnited States
-
Sameek RoychowdhuryNational Cancer Institute (NCI)WithdrawnLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | ALK Gene Mutation | Metastatic Malignant Neoplasm in the Brain | Advanced Malignant Neoplasm | ALK Fusion Protein Expression | Metastatic Malignant Neoplasm in the Central Nervous System | ROS1 Gene Mutation | ALK Gene... and other conditionsUnited States
-
AstraZenecaTerminatedInoperable Locally Advanced or Metastatic Biliary Tract CancerJapan
-
Megan Daly, MDEMD SeronoCompletedMetastatic Non-small Cell Lung Cancer (NSCLC)United States
-
Ronald LevyBristol-Myers SquibbCompletedAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Extracranial Solid NeoplasmUnited States
-
ElephasBeaufort CRORecruitingNSCLC | Non Small Cell Lung Cancer | Metastatic Non Small Cell Lung Cancer | Metastatic NSCLC - Non-Small Cell Lung CancerUnited States
-
Gilead SciencesRecruitingStage IV Breast Cancer | Locally Advanced or Unresectable Metastatic Breast CancerTaiwan, Korea, Republic of, Australia, Greece, Spain, United States, United Kingdom, France, Israel, Malaysia, Japan, Belgium, Poland, China, Germany, Czechia, Singapore, Hungary, Brazil, Italy, South Africa, Portugal, Argentina, Hong... and more
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.RecruitingLocally Advanced or Metastatic Epithelial TumorChina
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
University Hospital DresdenCompletedAdvanced or Metastatic Cholangiocellular Carcinoma and Bile DuctGermany
-
Dompé Farmaceutici S.p.AWithdrawnFatigue | Locally Advanced or Metastatic Breast CancerUnited States, Italy, Germany
-
AstraZenecaActive, not recruitingLocally Advanced (Inoperable) or Metastatic Breast CancerUnited States, Italy, Spain, Belgium, Hungary, Poland, Canada, France, Germany, Korea, Republic of, Japan, Peru, Russian Federation, United Kingdom, China, Taiwan, Israel, Australia, Argentina
-
Elpiscience (Suzhou) Biopharma, Ltd.RecruitingSolid Tumor | Metastatic Solid Tumor | Locally Advanced Solid TumorChina
-
National Cancer Institute (NCI)RecruitingLocally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States, Puerto Rico
-
Beijing Biostar Pharmaceuticals Co., Ltd.Chengdu Biostar PharmaceuticalsSuspendedAdvanced or Metastatic CRCChina
-
Mirati Therapeutics Inc.NovartisActive, not recruitingMetastatic Cancer | Advanced Cancer | Malignant Neoplastic DiseaseUnited States
-
PfizerActive, not recruitingOvarian Cancer | NSCLC | Solid Tumors | Urothelial Cancer | Advanced MalignanciesHungary, Spain, United States, Canada, Taiwan, Japan, Serbia, Italy, New Zealand, Australia, Mexico, Russian Federation, United Kingdom, France, Korea, Republic of, Belgium, Poland, Denmark, Israel
-
SOTIO Biotech AGRecruitingAdvanced Solid Tumor | Metastatic Solid TumorUnited States, Spain, Czechia, Belgium, France
-
AmgenActive, not recruitingAdvanced/Metastatic Solid Tumors With KRAS p.G12C MutationTaiwan, Hong Kong
-
OncoMed Pharmaceuticals, Inc.TerminatedMetastatic Cancer | Locally Advanced Malignant NeoplasmUnited States
-
Incyte CorporationTerminatedMetastatic Cancer | Solid Tumors | Advanced MalignanciesUnited States
-
Incyte CorporationNovartis PharmaceuticalsCompletedSolid Tumor | Metastatic Cancer | Advanced CancerUnited States
-
Merus N.V.Chiltern International Inc.; Q2 Solutions; Oncology Therapeutic Development (OTD) and other collaboratorsRecruitingGastric Cancer | Colorectal Cancer | NSCLC | Head and Neck Squamous Cell Carcinoma | HNSCC | Advanced/Metastatic Solid Tumors | Gastroesophageal-junction CancerUnited States, Spain, Belgium, France, Netherlands, United Kingdom
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
Nykode Therapeutics ASANektar Therapeutics; Vaccibody ASCompletedLocally Advanced or Metastatic Solid TumoursGermany
-
Astellas Pharma Global Development, Inc.AvailableMetastatic Gastroesophageal Junction (GEJ) Adenocarcinoma | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma Cancer | Metastatic Gastric Adenocarcinoma CancerUnited States, Germany
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMetastatic Malignant Neoplasm in the Liver | Advanced Malignant Neoplasm | Refractory Malignant Neoplasm | Colorectal Carcinoma Metastatic in the LiverUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Auransa, Inc.RecruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Advanced Hepatocellular Carcinoma | Metastatic Malignant Neoplasm in the Liver | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Advanced CholangiocarcinomaUnited States
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Switzerland, United States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Unresectable MelanomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States, Canada
-
iTeos Belgium SARecruitingMetastatic NSCLC | Stage III NSCLCUnited States, Belgium, Spain, Switzerland, Italy, France, Canada, Poland, Czechia
-
Jiangsu Province Nanjing Brain HospitalRecruiting
-
The University of Hong KongResearch Grants Council, Hong KongRecruitingFear of Cancer Progression | Metacognition-based Intervention | Supportive-expressive Based Intervention | Psychooncology | Advanced or Metastatic CancerHong Kong
-
Janssen Research & Development, LLCRecruitingAdvanced or Metastatic Colorectal CancerUnited States, Korea, Republic of, Taiwan, Malaysia, Germany, Italy, Spain, Belgium, Canada, Puerto Rico, China
-
Nerviano Medical SciencesTerminated
-
PfizerCompletedLocally Advanced or Metastatic NRAS Mutant MelanomaUnited States, Australia, Germany, Italy, Netherlands
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; Gilead Sciences; Nektar TherapeuticsRecruitingLocally Advanced or Metastatic Urothelial CarcinomaKorea, Republic of, United States, Taiwan, Australia, United Kingdom, France, Greece, Italy, Belgium, Spain, Canada, Denmark, Germany
-
Tayu Huaxia Biotech Medical Group Co., Ltd.RecruitingLocally Advanced /Metastatic Solid Tumors | Relapsed or Refractory LymphomasChina
-
Jo ChienMerck Sharp & Dohme LLCCompletedTriple Negative Breast Cancer | Advanced or Metastatic Breast CancerUnited States
-
Radiotherapy Oncology Centre "Santa Maria" HospitalPaola Anselmo,MD; Michelina Casale,PhD; Fabio Trippa,MDRecruitingNSCLC | Non Small Cell Lung Cancer | EGF-R Positive Non-Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | NSCLC Stage IV | Oligometastatic Disease | Non-Small Cell Squamous Lung Cancer | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor | Non-Small Cell Adenocarcinoma and other conditionsItaly
-
University Hospital, EssenGerman Cancer AidNot yet recruitingAdvanced Lung Carcinoma | NSCLC Stage IV | NSCLC Stage IIIB | First Line Treatment | Second Line Treatment | Palliative Treatment | NSCLC Stage IIICGermany
-
Seoul National University Bundang HospitalRoche Pharma AG; Korean Cancer Study GroupRecruitingSolid Tumor | Metastatic Cancer | Advanced Solid TumorKorea, Republic of
-
M.D. Anderson Cancer CenterTerminatedLocally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
EpicentRx, Inc.TerminatedMetastatic Cancer | Advanced Cancer | Malignant Solid TumorUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Metastatic Solid TumorsFrance, Netherlands, Spain, Canada, Singapore, Germany, Korea, Republic of, Australia, Belgium, Switzerland, Italy, United States